Bacteria in the gut linked to efficacy of immunotherapy
In this study, the investigators looked at the different types [...]
Sarcopenia is prevalent in kidney cancer patients treated with cabozantinib
Sarcopenia is the loss of muscle mass along with reduced [...]
Pembrolizumab plus axitinib combination declined for first-line treatment of advanced kidney cancer
The National Institute for Health and Care Excellence (NICE) have issued [...]
A survey about the effect of COVID-19 on kidney cancer patients
Towards the end of June, some of you will have [...]
Clinical research cut by 87% at peak of COVID-19 pandemic
Research from University College London published in PLOS One estimated [...]
NOTION: iN-home sampling Of cyTokines in ImmunOtherapy patieNts
NOTION is a research study to develop an early detection [...]
Treatment of kidney cancer during the coronavirus pandemic
COVID-19 continues to affect the care of patients with metastatic [...]
Scotland’s plan to remobilise and redesign cancer services
The Government in Scotland has published a new plan to [...]
Pazopanib for poor risk kidney cancer patients
Pazopanib is used for first-line metastatic RCC treatment, but the [...]
Outcomes of complete metastasectomy in metastastic kidney cancer
A recent study from Canada investigated the use of surgery [...]
